Netherlands Enterprise Agency
Investor profile
Venture capital
Deals
8
distinct rounds
Companies
8
backed
Active span
2019–2024
6 yrs
Total round €
€57M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- Oost NL2
- ABN AMRO Asset Based Finance1
- Active Partners1
- Brightlands Venture Partners1
- C4 Ventures1
- Fairtree Elevant Ventures1
- FibrXL1
- Flerie Invest1
- Hyloris Pharmaceuticals1
- InnovatieKrediet1
- Lumana Invest1
- NV Industriebank LIOF1
- River Capital1
- Rubio Impact Ventures1
- RVO.nl1
- S&T Ventures1
- Tama1
- Willow Capital Investments1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Pleco Therapeutics | Netherlands | 1 | €17M |
| Neuroplast | Netherlands | 1 | €10M |
| Healix | Netherlands | 1 | €10M |
| Meatable | Netherlands | 1 | €7.6M |
| Amarna Therapeutics | Netherlands | 1 | €5.0M |
| NoPalm Ingredients | Netherlands | 1 | €5.0M |
| Orbital Eye | Netherlands | 1 | €2.0M |
| Maxwell | Netherlands | 1 | €400k |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Pleco Therapeutics | Series A | €17M | 2022-09 |
| Healix | Seed | €10M | 2021-09 |
| Neuroplast | Series B | €10M | 2021-11 |
| Meatable | Other | €7.6M | 2024-09 |
| NoPalm Ingredients | Seed | €5.0M | 2024-07 |
| Amarna Therapeutics | Other | €5.0M | 2021-12 |
| Orbital Eye | Other | €2.0M | 2023-12 |
| Maxwell | Seed | €400k | 2019-03 |